277 related articles for article (PubMed ID: 33356659)
1. Thioredoxin-dependent system. Application of inhibitors.
Jastrząb A; Skrzydlewska E
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):362-371. PubMed ID: 33356659
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Thioredoxin System for Cancer Therapy.
Zhang J; Li X; Han X; Liu R; Fang J
Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Thioredoxin System as a Strategy for Cancer Therapy.
Bian M; Fan R; Zhao S; Liu W
J Med Chem; 2019 Aug; 62(16):7309-7321. PubMed ID: 30963763
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin system modulation by plant and fungal secondary metabolites.
Dal Piaz F; Braca A; Belisario MA; De Tommasi N
Curr Med Chem; 2010; 17(5):479-94. PubMed ID: 19941471
[TBL] [Abstract][Full Text] [Related]
6. Studies toward novel peptidomimetic inhibitors of thioredoxin-thioredoxin reductase system.
Kłossowski S; Muchowicz A; Firczuk M; Swiech M; Redzej A; Golab J; Ostaszewski R
J Med Chem; 2012 Jan; 55(1):55-67. PubMed ID: 22128876
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
9. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
[TBL] [Abstract][Full Text] [Related]
11. The effects of acrolein on the thioredoxin system: implications for redox-sensitive signaling.
Myers CR; Myers JM; Kufahl TD; Forbes R; Szadkowski A
Mol Nutr Food Res; 2011 Sep; 55(9):1361-74. PubMed ID: 21812108
[TBL] [Abstract][Full Text] [Related]
12. Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.
Sun Y; Rowehl LM; Huang L; Mackenzie GG; Vrankova K; Komninou D; Rigas B
Breast Cancer Res; 2012 Jan; 14(1):R20. PubMed ID: 22293394
[TBL] [Abstract][Full Text] [Related]
13. A novel antioxidant mechanism of ebselen involving ebselen diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase.
Zhao R; Holmgren A
J Biol Chem; 2002 Oct; 277(42):39456-62. PubMed ID: 12177067
[TBL] [Abstract][Full Text] [Related]
14. Ebselen: a thioredoxin reductase-dependent catalyst for alpha-tocopherol quinone reduction.
Fang J; Zhong L; Zhao R; Holmgren A
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):103-9. PubMed ID: 15979675
[TBL] [Abstract][Full Text] [Related]
15. Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells.
Liang YW; Zheng J; Li X; Zheng W; Chen T
Eur J Med Chem; 2014 Sep; 84():335-42. PubMed ID: 25036792
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione.
Lu J; Vlamis-Gardikas A; Kandasamy K; Zhao R; Gustafsson TN; Engstrand L; Hoffner S; Engman L; Holmgren A
FASEB J; 2013 Apr; 27(4):1394-403. PubMed ID: 23248236
[TBL] [Abstract][Full Text] [Related]
17. The thioredoxin system and cancer therapy: a review.
Mohammadi F; Soltani A; Ghahremanloo A; Javid H; Hashemy SI
Cancer Chemother Pharmacol; 2019 Nov; 84(5):925-935. PubMed ID: 31367788
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
Liu Y; Li Y; Yu S; Zhao G
Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886
[TBL] [Abstract][Full Text] [Related]
19. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells.
Myers CR; Myers JM
Toxicology; 2009 Mar; 257(1-2):95-104. PubMed ID: 19135121
[TBL] [Abstract][Full Text] [Related]
20. Bacterial thioredoxin and thioredoxin reductase as mediators for epigallocatechin 3-gallate-induced antimicrobial action.
Liang W; Fernandes AP; Holmgren A; Li X; Zhong L
FEBS J; 2016 Feb; 283(3):446-58. PubMed ID: 26546231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
